Abstract:Introduction: The liver enriched transcription factor HNF-6 (OC-1) is expressed in the embryonic and mature hepatocytes and bile duct epithelia, and has potential DNA binding sites for numerous hepatic target genes involved in critical liver function. The relevance of HNF-6 in liver development and function is illustrated in the HNF-6 knock out mice where the extra and intrahepatic bile ducts are abnormally differentiated and animals developed non obstructive cholestatic injury. Hypothesis: HNF-6 regulates in vivo hepatic genes involved in bile acid metabolism. Methods: CD1 mice underwent common bile duct ligation (BDL) (n = 4) or sham operation (SH) (n = 2) for 24 hours and the effects of biliary obstruction on the expression of hepatic HNF-6 and its in vivo target genes involved in bile acid transport and synthesis are examined. Whole liver total RNA was extracted for RNAse protection analyses. Data were collected on the Phosphoimager and analyzed by the ImageQuant program. Differences in mRNA signals between groups were evaluated by the student t test. Results: A 4 fold reduction in HNF-6 mRNA expression in BDL samples relative to SH samples (p = 0.005) is associated with a 3 fold (p = 0.001) and a 10 fold (p = 0.005) downregulation in the sodium dependent taurocholate bile acid transporter NTCP and the bile acid synthesis enzyme Cholesterol 7α hydroxylase (CYP7A1) respectively, but a 7 fold upregulation in the apical bile acid transporter protein (ABAT). Overexpression of HNF-6 mRNA and protein in liver following 48 hours of recombinant adenovirus expressing HNF-6 cDNA (AdH6 n = 3) or control LacZ (n = 2) by tail vein injection showed a 4 fold upregulation of Cyp7A1 (p = 0.03) but no effect on NTCP, or ASBT expression in AdH6 infected liver. Electromobility shift assay using liver nuclear protein extracts, HNF-6 antibody and oligonucleotide of the CYP7A1 promoter bearing the DNA consensus sequences for HNF-6 binding confirmed that the mouse Cyp7A1 promoter at nt -1442/–1429 contains a binding site for HNF-6. Conclusions: CYP7A1 is a likely in vivo target gene for HNF-6. The downregulation of HNF-6 transcription factor expression in association with a reduction in Cyp7A1 during biliary obstruction is a likely protective mechanism to further limit the production and therefore the excess of intracellular toxic bile acids accumulated during cholestasis.

HCBP6 Modulates Triglyceride Homeostasis in Hepatocytes via the SREBP1c/FASN Pathway.

HCBP6 Upregulates Human SREBP1c Expression by Binding to C/EBPβ-binding Site in the SREBP1c Promoter

Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6

HCBP6-induced activation of brown adipose tissue and upregulated of BAT cytokines genes

Activating Transcription Factor 6 Inhibits Transcriptional Activity of SREBP1 in Hepatocytes

Hepatocyte Nuclear Factor HNF-6 Regulates Hepatic Cholesterol 7 Alpha-Hydroxylase (CYP7A1) During Liver Injury from Biliary Obstruction

ATF6 Modulates SREBP2-mediated Lipogenesis

In Vivo Regulation Of Murine Cyp7a1 By Hnf-6: A Novel Mechanism For Diminished Cyp7a1 Expression In Biliary Obstruction

MicroRNA-185-5p Mediates Regulation of SREBP2 Expression by Hepatitis C Virus Core Protein

The Metabolic Regulator Small Heterodimer Partner Contributes to the Glucose and Lipid Homeostasis Abnormalities Induced by Hepatitis C Virus Infection

Hepatitis B Virus X Protein Regulates Lipid Metabolism and Promotes the Proliferation of Liver Cancer Cells Via the C/EBPa/SREBP-1 Pathway

SIRT6 Controls Hepatic Lipogenesis by Suppressing LXR, ChREBP, and SREBP1.

Hepatitis B Small Surface Protein Hijacking Bip is Initial and Essential to Promote Lipid Synthesis

Integrator complex subunit 6 promotes hepatocellular steatosis via β-catenin-PPARγ axis

Molecular mechanism of SREBP-1c expression regulated by HCV core protein

A Mutant of HBx （hbxδ127） Promotes Hepatoma Cell Growth Via Sterol Regulatory Element Binding Protein 1c Involving 5-Lipoxygenase

Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner

SREBP-1a Activation by HBx and the Effect on Hepatitis B Virus Enhancer II/core Promoter.

Activating transcription factor (ATF) 6 upregulates cystathionine β synthetase (CBS) expression and hydrogen sulfide (H2S) synthesis to ameliorate liver metabolic damage

HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.

Hepatitis B Virus X Protein Binding To Hepsin Promotes C3 Production By Inducing Il-6 Secretion From Hepatocytes